Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-199-4 | CAS number: 104-40-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- publication
- Title:
- Mass spectrometric determination of p-nonylphenol metabolism and disposition following oral administration to Sprague-Dawley rats
- Author:
- Daniel R. Doergea,*, Nathan C. Twaddlea, Mona I. Churchwella, Hebron C. Changa, Retha R. Newboldb, K. Barry Delclosa
- Year:
- 2 002
- Bibliographic source:
- Reproductive Toxicology 16 (2002) 45–56
Materials and methods
- Objective of study:
- toxicokinetics
- Principles of method if other than guideline:
- In Vivo metabolism and disposition study of p-nonylphenol in rat
- GLP compliance:
- not specified
Test material
- Reference substance name:
- p-nonylphenol
- EC Number:
- 203-199-4
- EC Name:
- p-nonylphenol
- Cas Number:
- 104-40-5
- Molecular formula:
- C15H24O
- IUPAC Name:
- 4-nonylphenol
- Details on test material:
- - Name of test material (as cited in study report): p-nonylphenol (NP)
- Molecular formula (if other than submission substance): C15-H24-O
- Molecular weight (if other than submission substance): 220.354 g/mole
- Substance type: Organic
- Physical state: No data available
- Impurities (identity and concentrations): 5% of branched side chain isomers of 2-NP
Constituent 1
- Radiolabelling:
- not specified
Test animals
- Species:
- rat
- Strain:
- other: CD (Sprague-Dawley)
- Sex:
- male/female
Administration / exposure
- Route of administration:
- other: Oral gavage and feed
- Vehicle:
- other: sesame oil and NP-fortified diets
- Details on exposure:
- The low serum NP levels measured in rats receiving the 750 ppm diet precluded a detailed study of NP toxicokinetics in these animals. The rats were removed from the control diet and within 4 h were administered NP by gavage at 50 mg/kg using a 50 mg/mL solution of NP in sesame oil.
- Duration and frequency of treatment / exposure:
- 141 days daily for feed and 4 h for gavage
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 25, 200 and 750 ppm (0, 0, 1.25, 10 and 50 mg/kgbw/day)and 50 mg/kg
- No. of animals per sex per dose / concentration:
- 6 male, 6 female
- Control animals:
- yes, concurrent vehicle
- Positive control reference chemical:
- No data available
- Details on study design:
- The low serum NP levels measured in rats receiving the 750 ppm diet precluded a detailed study of NP toxicokinetics in these animals. Animals receiving 25 ppm diet would not contain detectable serum levels of NP. Therefore, the six male and six female littermates that had been maintained on the 25 ppm NP-fortified diet until PND 115 were placed on the control diet for one month prior to use in a toxicokinetic gavage exposure study on PND 145.No overt toxicity was observed in the 50-day NP dose range-finding study below 500 ppm and the one month period on control diet was predicted to reverse any enzyme induction that might have occurred. The rats were removed from the control diet and within 4 h was administered NP by gavage at 50 mg/kg using a 50 mg/mL solution of NP in sesame oil. Blood was collected from the tail vein of each rat at 0.25–12 h, allowed to clot at 0°C for 30 min, then centrifuged to produce serum, and aliquots were frozen at 70°C until analysis.
Results and discussion
- Preliminary studies:
- Yes, no overt toxicity was observed in the 50-day NP dose range-finding study below 500 ppm.
Main ADME resultsopen allclose all
- Type:
- absorption
- Results:
- NP was rapidly absorped
- Type:
- distribution
- Results:
- Distributed in serum,kidney, livers, brain and Placental transfer
- Type:
- metabolism
- Results:
- Rapied first-pass metabolism
- Type:
- excretion
- Results:
- Rapidly eliminated by glucuronidation
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- NP was rapidly absorped
- Details on distribution in tissues:
- No significant sex difference in the distribution was observed at any time point or overall in treated rats. The largest difference between females and males was observed in the livers with more similar levels observed in kidney and brain. Reproductive tissues generally contained low levels of total NP with the exception of prostate. The aglycone content was measured in livers from rats on the 50 mg/kg diet. Female livers contained an average of 44% aglycone and male livers contained an average of 13% aglycone. Female brains were found to contain NP aglycone levels that averaged 57% of total NP. Placental transfer into serum and brain in pregnant female rats.
- Details on excretion:
- Rapied first-pass metabolism were observed and Two major glucuronides were observed in rat serum and liver by LC-ES/MS analysis. Substantial amounts of NP-catechol glucuronides were also observed in serum and liver.
Toxicokinetic parameters
- Toxicokinetic parameters:
- AUC: Male - 240 61, Female -350 77
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Yes , NP-glucuronides and putative nonylcatechol-glucuronides
Any other information on results incl. tables
Levels of total NP in female rat tissue. NP was determined in the indicated tissues in nmol/g using LC-APCI/MS as described in the Methods section.
The values shown have been adjusted for the responses observed in the respective control tissue and represent means ± SD for n = 6. The limit of quantification (LOQ) in serum was approximately 0.23 μM. Samples not analyzed are designated NA.
Dietary Dose |
Serum |
Liver |
Kidney |
Uterus |
Brain |
Mammary |
Ovary |
750 ppm-female |
0.93 ± 0.28 |
8.1 ± 8.6 |
2.4 ± 2.4 |
0.080 ± 0.11 |
1.4 ± 1.2 |
< LOQ |
< LOQ |
200 ppm |
< LOQ |
3.5 ± 1.7 |
NA |
NA |
NA |
NA |
NA |
Levels of total NP in male rat tissue. NP was determined in the indicated tissues in nmol/g using LC-APCI/MS as described in the Methods section.
The values shown have been adjusted for the responses observed in the respective control tissue and represent means ± SD for n = 6. Samples not analyzed are designated NA
Dietary Dose |
Serum |
Liver |
Kidney |
Prostate |
Brain |
Testes |
750 ppm |
0.35 ± 0.20 |
2.6 ± 3.2 |
2.1 ± 2.0 |
0.82 ± 0.11 |
0.42 ± 0.70 |
< LOQ |
200 ppm |
< LOQ |
1.6 ± 1.7 |
NA |
NA |
NA |
NA |
Toxicokinetics of NP following gavage administration of 50 mg/kg to male and female rats. Area under the concentration-time curves, elimination and absorption half-times were determined graphically for individual rats as described in the Methods section and values shown represent means ± SD (n = 6)
Sex |
t1/2Elim (h) |
t1/2Abs (h) |
AUC (μ Mh) |
Male |
3.1 ± 0.52 |
0.37 ± 0.14 |
240 ± 61 |
Female |
4.0 ± 1.5 |
0.90 ± 0.70 |
350 ± 77a |
aStatistically different from male AUC data (P < 0.02).
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): low bioaccumulation potential based on study results
On the basis of observed result it is concluded the p-nonylphenol have rapide absorption and elimination. Metabolisum is gender-specific and distribution is aglycone estrogen-responsive. Hance, expected to have Low bio-accumulation potential based on study results. - Executive summary:
In a in vivometabolism and disposition study,CD (Sprague-Dawley) male and female rats were treated with p-nonylphenol orally by gavage at 0, 0, 1.25, 10 and 50 mg/kgbw/day and by feed 50 mg/kg. It was observed that p-nonylphenol were rapidly absorbed in serum. The largest difference between females and males was observed in the livers with more similar levels observed in kidney and brain. Reproductive tissues generally contained low levels of total NP with the exception of prostate. The aglycone content was measured in livers from rats on the 50 mg/kg diet. Female livers contained an average of 44% aglycone and male livers contained an average of 13% aglycone. Female brains were found to contain NP aglycone levels that averaged 57% of total NP. Placental transfer into serum and brain were observed in pregnant female rats. NP was rapidly eliminated by glucuronidation from serum. The higher tissue concentrations of total NP in females as compared to males in relative serum concentrations were observed. However, the much higher levels of total NP in female livers, coupled with the higher levels of aglycone, suggest that gender-specific metabolic factors affecting clearance. The active aglycone form can still accumulate in estrogen-responsive tissues of rats. Therefore, On the basis of observed result it is concluded the p-nonylphenol have rapide absorption and elimination. Metabolisum is gender-specific and distribution is aglycone estrogen-responsive. Hance, expected to have Low bio-accumulation potential based on study results.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
